IP And Trademarks 20 October 2026
Delhi High Court Sets Ruxolitinib Patent Hearing Date
Delhi High Court has set a hearing date for the ruxolitinib patent infringement case, with the drug’s patent slated to expire in just eleven weeks. The decision could affect market entry for generic versions and has drawn attention from pharma companies and IP lawyers across India.
The Delhi High Court has scheduled a hearing on the ruxolitinib patent infringement case, with the patent set to lapse in eleven weeks.
- Patent expiration in 11 weeks
- Court hearing date now fixed
- Potential impact on generic drug market
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.